Literature DB >> 71995

A clinical and urodynamic study of tadenan in the treatment of benign prostatic hypertrophy.

T Donkervoort, A Sterling, J van Ness, P J Donker.   

Abstract

20 patients with benign prostatic hypertrophy were admitted to a double-blind noncrossover study for evaluation of the effect of Tadenan. Using either standard clinical criteria or urodynamic data obtained by the urinary drop spectrometer, no significant effect was found for the dosage and period of administration used.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71995     DOI: 10.1159/000472101

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

Review 1.  Pygeum africanum for benign prostatic hyperplasia.

Authors:  T Wilt; A Ishani; R Mac Donald; I Rutks; G Stark
Journal:  Cochrane Database Syst Rev       Date:  2002

2.  Pygeum africanum: effect on oxidative stress in early diabetes-induced bladder.

Authors:  Dan Wang; Yongzhi Li; Guihua Hou; Ping Wang; Jianping Zhang; Vincent Laudon; Benkang Shi
Journal:  Int Urol Nephrol       Date:  2009-07-16       Impact factor: 2.370

3.  Candicidin treatment of prostatism: a prospective double-blind placebo-controlled study.

Authors:  K M Jensen; P O Madsen
Journal:  Urol Res       Date:  1983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.